Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis.

MLA

Bas, Onur, et al. “Infectious Complications of Cyclin-Dependent Kinases 4 and 6 Inhibitors in Patients with Hormone-Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.” Supportive Care in Cancer, vol. 30, no. 11, Nov. 2022, pp. 9071–78. EBSCOhost, https://doi.org/10.1007/s00520-022-07320-y.

APA

Bas, O., Erul, E., Guven, D. C., & Aksoy, S. (2022). Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis. Supportive Care in Cancer, 30(11), 9071–9078. https://doi.org/10.1007/s00520-022-07320-y

Chicago

Bas, Onur, Enes Erul, Deniz Can Guven, and Sercan Aksoy. 2022. “Infectious Complications of Cyclin-Dependent Kinases 4 and 6 Inhibitors in Patients with Hormone-Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.” Supportive Care in Cancer 30 (11): 9071–78. doi:10.1007/s00520-022-07320-y.